Abstract
Pigment Yellow 74 (PY74) is a monoazo pigment that is used in yellow tattoo inks. The metabolism of PY74 was investigated using rat liver and human liver microsomes and expressed human cytochromes P450 (P450s). Two phase I metabolites were isolated and characterized by mass spectrometry and NMR techniques. One metabolite (PY74-M1) was a ring hydroxylation product of PY74, 2-((2-methoxy-4-nitrophenyl)azo)-N-(2-methoxy-4-hydroxyphenyl)-3-oxobutanamide. The second metabolite (PY74-M2) was identified as 2-((2-hydroxy-4-nitrophenyl)azo)-N-(2-methoxy-4-hydroxyphenyl)-3-oxobutanamide, which is the O-demethylation product of PY74-M1. These metabolites were formed by in vitro incubations of PY74 with 3-methylcholanthrene-induced rat liver microsomes and to a much lesser extent by liver microsomes from untreated or phenobarbital-induced rats. The role for CYP1A in the metabolism of PY74 was confirmed using expressed human P450s. The catalytic ability of the P450s for metabolism of PY74 was CYP 1A2 > CYP 1A1 > CYP 3A4 ≈ CYP 1B1 (no activity with CYP 2B6, 2C9, 2D6 or 2E1). The metabolism of PY74-M1 to PY74-M2 was catalyzed only by CYP 1A2 and CYP 1A1 (no activity from CYP 1B1, 2B6, 2C9, 2D6, 2E1, or 3A4). These results demonstrate that the tattoo pigment PY74 is metabolized in vitro by P450 to metabolites that should be available for phase II metabolism and excretion.
Footnotes
-
The contents of this manuscript do not necessarily reflect the views or policies of the U.S. Food and Drug Administration, nor does the mention of trade names or commercial products constitute endorsement or recommendation for use. Y. Cui was supported by an appointment to the Oak Ridge Affiliated Universities Research Program at the National Center for Toxicological Research, administered through an interagency agreement between the U.S. Department of Energy and the U.S. Food and Drug Administration. The funding support from the Office of Food Additive Safety, Center for Food Safety and Applied Nutrition (CFSAN), U.S. Food and Drug Administration is acknowledged. The NTP Center for Phototoxicology is supported in part by an Interagency Agreement (IAG 224-93-0001) between the U.S. Food and Drug Administration and the U.S. National Institute for Environmental Health Sciences.
-
Article, publication date, and citation information can be found at http://dmd.aspetjournals.org.
-
doi:10.1124/dmd.104.003285.
-
ABBREVIATIONS: PY74, Pigment Yellow 74; PY74-M1, metabolite 1 of PY74; PY74-M2, metabolite 2 of PY74; BSA, bovine serum albumin; 3-MC, 3-methylcholanthrene; HPLC, high performance liquid chromatography; P450, cytochrome P450; PB, phenobarbital; MS, mass spectrometry; APCI, atmospheric pressure chemical ionization; FDA, Food and Drug Administration.
- Received December 10, 2004.
- Accepted July 8, 2005.
- The American Society for Pharmacology and Experimental Therapeutics
DMD articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|